These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7544032)

  • 1. [Multiple sclerosis].
    Nyland H; Myhr KM
    Tidsskr Nor Laegeforen; 1995 Jun; 115(17):2072-7. PubMed ID: 7544032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: clinical presentation, diagnosis and treatment.
    Brod SA; Lindsey JW; Wolinsky JS
    Am Fam Physician; 1996 Sep; 54(4):1301-6, 1309-11. PubMed ID: 8816574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple sclerosis].
    Confavreux C; Gignoux L
    Rev Prat; 2002 Mar; 52(5):529-38. PubMed ID: 11949507
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognosis in multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1997 Mar; 127(12):500-5. PubMed ID: 9148400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K; Saida T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in multiple sclerosis. A review.
    Truyen L
    Acta Neurol Belg; 1994; 94(2):98-102. PubMed ID: 8036883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study with localized proton magnetic resonance spectroscopy of 31 multiple sclerosis lesions: correlations with clinical and MRI features].
    Viala K; Stievenart JL; Cabanis EA; Lyon-Caen O; Tourbah A
    Rev Neurol (Paris); 2001 Jan; 157(1):35-44. PubMed ID: 11240546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuating corticosteroid-responsive auditory neuropathy/dyssynchrony is suggestive of central nervous system pathology.
    Mallur PS; Lalwani AK
    Otol Neurotol; 2007 Dec; 28(8):1002-4. PubMed ID: 17921910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical picture and therapy of multiple sclerosis].
    Schrader A
    Wien Med Wochenschr; 1972 Mar; 122(10):129-34. PubMed ID: 4334261
    [No Abstract]   [Full Text] [Related]  

  • 13. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial.
    Krapf H; Morrissey SP; Zenker O; Zwingers T; Gonsette R; Hartung HP;
    Neurology; 2005 Sep; 65(5):690-5. PubMed ID: 16157900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The interest of multiple sclerosis attacks. Physiopathology and therapy].
    de Andrés C
    Rev Neurol; 2003 Jun 1-15; 36(11):1058-64. PubMed ID: 12808503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.